Interestingly, an effect on podocin expression was only seen in suPAR but not in TNF treated mouse podocytes, while TNF treatment increased the effects of suPAR on podocin expression and TRPC6 localization, suggesting that multiple circulating factors might contribute to primary FSGS. This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.